Symrise Touts Green, Biotech Developments In Scent & Care, Raises FY 2022 Growth Target
Symrise AG is now projecting organic sales growth ‘significantly higher’ than 7%, versus a previous estimate of 5% to 7%. The German fragrance and flavors firm, which recorded a 10.2% increase in organic sales in the fiscal 2022 first half, pointed to Hydrolite 8 green and its partnership with biotech Evoxx Technologies among other innovation-minded moves to meet cosmetics demand.
You may also be interested in...
With biotech, “the entire tree of life starts to become accessible to us ethically and sustainably,” says Arcaea CEO Jasmina Aganovic. Her company, launched in October 2021, is developing custom keratin molecules for skin and hair, as well as new UV filter technology, among other innovations to expand formulators’ toolkits, not just replace problematic ingredients.
Revlon approved for $1.4bn debtor-in-possession financing from BrandCo Lenders, a group of operating subsidiaries formed in capital structure changes which owns much of Revlon’s intellectual property. Firm appoints interim CFO to set course for debt restructuring.
E.l.f. Beauty’s sales grew 26% to $122.6m in the fiscal 2023 first quarter, leading the Oakland, CA-based firm to increase full-year projections. According to company leadership, e.l.f. is capturing market share at a rapid clip while expanding distribution, notably in pharmacy retail.